Literature DB >> 21617132

What is the oncologic risk of stem cell treatment for heart disease?

Konstantinos E Hatzistergos, Arnon Blum, Tan Ince, James M Grichnik, Joshua M Hare.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21617132      PMCID： PMC3390911          DOI： 10.1161/CIRCRESAHA.111.246611

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  47 in total

1.  Retraction: Spontaneous human adult stem cell transformation.

Authors:  Ricardo de la Fuente; Antonio Bernad; Javier Garcia-Castro; Maria C Martin; Juan C Cigudosa
Journal:  Cancer Res       Date:  2010-08-15       Impact factor: 12.701

2.  Spontaneous malignant transformation of human mesenchymal stem cells reflects cross-contamination: putting the research field on track - letter.

Authors:  Anja Torsvik; Gro V Røsland; Agnete Svendsen; Anders Molven; Heike Immervoll; Emmet McCormack; Per Eystein Lønning; Monika Primon; Ewa Sobala; Joerg-Christian Tonn; Roland Goldbrunner; Christian Schichor; Josef Mysliwietz; Tamara T Lah; Helena Motaln; Stian Knappskog; Rolf Bjerkvig
Journal:  Cancer Res       Date:  2010-07-14       Impact factor: 12.701

3.  Gene expression profiles following intracoronary injection of mesenchymal stromal cells using a porcine model of chronic myocardial infarction.

Authors:  Javier Barallobre-Barreiro; Oskar Martínez de Ilárduya; Isabel Moscoso; Ramón Calviño-Santos; Guillermo Aldama; Alberto Centeno; Eduardo López-Pelaez; Nieves Doménech
Journal:  Cytotherapy       Date:  2010-11-15       Impact factor: 5.414

4.  Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation.

Authors:  Konstantinos E Hatzistergos; Henry Quevedo; Behzad N Oskouei; Qinghua Hu; Gary S Feigenbaum; Irene S Margitich; Ramesh Mazhari; Andrew J Boyle; Juan P Zambrano; Jose E Rodriguez; Raul Dulce; Pradip M Pattany; David Valdes; Concepcion Revilla; Alan W Heldman; Ian McNiece; Joshua M Hare
Journal:  Circ Res       Date:  2010-07-29       Impact factor: 17.367

5.  Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity.

Authors:  Henry C Quevedo; Konstantinos E Hatzistergos; Behzad N Oskouei; Gary S Feigenbaum; Jose E Rodriguez; David Valdes; Pradip M Pattany; Juan P Zambrano; Qinghua Hu; Ian McNiece; Alan W Heldman; Joshua M Hare
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-05       Impact factor: 11.205

6.  Genetically transforming human mesenchymal stem cells to sarcomas: changes in cellular phenotype and multilineage differentiation potential.

Authors:  Nan Li; Rui Yang; Wendong Zhang; Howard Dorfman; Pulivarthi Rao; Richard Gorlick
Journal:  Cancer       Date:  2009-10-15       Impact factor: 6.860

7.  A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction.

Authors:  Joshua M Hare; Jay H Traverse; Timothy D Henry; Nabil Dib; Robert K Strumpf; Steven P Schulman; Gary Gerstenblith; Anthony N DeMaria; Ali E Denktas; Roger S Gammon; James B Hermiller; Mark A Reisman; Gary L Schaer; Warren Sherman
Journal:  J Am Coll Cardiol       Date:  2009-12-08       Impact factor: 24.094

8.  Rb regulates fate choice and lineage commitment in vivo.

Authors:  Eliezer Calo; Jose A Quintero-Estades; Paul S Danielian; Simona Nedelcu; Seth D Berman; Jacqueline A Lees
Journal:  Nature       Date:  2010-08-04       Impact factor: 49.962

9.  Direct injection of autologous mesenchymal stromal cells improves myocardial function.

Authors:  Yifu Zhou; Suna Wang; Zuxi Yu; Robert F Hoyt; Vandana Sachdev; Pamela Vincent; Andrew E Arai; Minjung Kwak; Sandra Sczerba Burkett; Keith A Horvath
Journal:  Biochem Biophys Res Commun       Date:  2009-10-21       Impact factor: 3.575

10.  Monitoring the genomic stability of in vitro cultured rat bone-marrow-derived mesenchymal stem cells.

Authors:  Dana Foudah; Serena Redaelli; Elisabetta Donzelli; Angela Bentivegna; Mariarosaria Miloso; Leda Dalprà; Giovanni Tredici
Journal:  Chromosome Res       Date:  2009-12-02       Impact factor: 5.239
View more
  18 in total

Review 1.  Cardiac cell therapy: boosting mesenchymal stem cells effects.

Authors:  E Samper; A Diez-Juan; J A Montero; P Sepúlveda
Journal:  Stem Cell Rev Rep       Date:  2013-06       Impact factor: 5.739

Review 2.  Endogenous and exogenous cell-based pathways for recovery from acute respiratory distress syndrome.

Authors:  Jeffrey E Gotts; Michael A Matthay
Journal:  Clin Chest Med       Date:  2014-09-24       Impact factor: 2.878

3.  Mesenchymal Stem Cells in Cardiology.

Authors:  Ian A White; Cristina Sanina; Wayne Balkan; Joshua M Hare
Journal:  Methods Mol Biol       Date:  2016

4.  Rationale and Design of the SENECA (StEm cell iNjECtion in cAncer survivors) Trial.

Authors:  Roberto Bolli; Joshua M Hare; Timothy D Henry; Carrie G Lenneman; Keith L March; Kathy Miller; Carl J Pepine; Emerson C Perin; Jay H Traverse; James T Willerson; Phillip C Yang; Adrian P Gee; João A Lima; Lem Moyé; Rachel W Vojvodic; Shelly L Sayre; Judy Bettencourt; Michelle Cohen; Ray F Ebert; Robert D Simari
Journal:  Am Heart J       Date:  2018-04-04       Impact factor: 4.749

Review 5.  The promising role of autologous and allogeneic mesenchymal stromal cells in managing knee osteoarthritis. What is beyond Mesenchymal stromal cells?

Authors:  Vivek Pandey; Sandesh Madi; Pawan Gupta
Journal:  J Clin Orthop Trauma       Date:  2022-02-09

Review 6.  Mesenchymal stem cells as a treatment for peripheral arterial disease: current status and potential impact of type II diabetes on their therapeutic efficacy.

Authors:  Jinglian Yan; Guodong Tie; Ting Yu Xu; Katharine Cecchini; Louis M Messina
Journal:  Stem Cell Rev Rep       Date:  2013-06       Impact factor: 5.739

7.  Strategies for improving animal models for regenerative medicine.

Authors:  Jose Cibelli; Marina E Emborg; Darwin J Prockop; Michael Roberts; Gerald Schatten; Mahendra Rao; John Harding; Oleg Mirochnitchenko
Journal:  Cell Stem Cell       Date:  2013-03-07       Impact factor: 24.633

8.  Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial.

Authors:  Alan W Heldman; Darcy L DiFede; Joel E Fishman; Juan P Zambrano; Barry H Trachtenberg; Vasileios Karantalis; Muzammil Mushtaq; Adam R Williams; Viky Y Suncion; Ian K McNiece; Eduard Ghersin; Victor Soto; Gustavo Lopera; Roberto Miki; Howard Willens; Robert Hendel; Raul Mitrani; Pradip Pattany; Gary Feigenbaum; Behzad Oskouei; John Byrnes; Maureen H Lowery; Julio Sierra; Mariesty V Pujol; Cindy Delgado; Phillip J Gonzalez; Jose E Rodriguez; Luiza Lima Bagno; Didier Rouy; Peter Altman; Cheryl Wong Po Foo; Jose da Silva; Erica Anderson; Richard Schwarz; Adam Mendizabal; Joshua M Hare
Journal:  JAMA       Date:  2014-01-01       Impact factor: 56.272

Review 9.  Seeing stem cells at work in vivo.

Authors:  Amit K Srivastava; Jeff W M Bulte
Journal:  Stem Cell Rev Rep       Date:  2014-02       Impact factor: 5.739

Review 10.  Bone marrow-derived mesenchymal stem cells for the treatment of heart failure.

Authors:  Takuya Narita; Ken Suzuki
Journal:  Heart Fail Rev       Date:  2015-01       Impact factor: 4.214
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.